RecruitingNCT00064870
Alzheimer's Disease Genetics Study
National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD)
Sponsor
Indiana University
Enrollment
10,000 participants
Start Date
Jun 1, 2002
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of the Alzheimer's Disease Genetics Study is to identify the genes that are responsible for causing Alzheimer's Disease (AD). One of the ways in which the risk factor genes for late onset AD can be investigated is by identifying and collecting genetic material from families with multiple members diagnosed with AD or dementia.
Eligibility
Min Age: 18 Years
Inclusion Criteria7
- Two living family members diagnosed with AD or other dementia with any age of onset
- Biological samples available
- Fresh blood, or
- Immortalized lymphoblastic cell lines, or
- grams of frozen cerebral cortex; fixed samples are not accepted
- Please note: this study does not include genetic counseling; because no personal identifying information such as name or date of birth is attached to samples, results of individual tests are not available to participants or family members.
- Member of a family that was included in the National Institute of Mental Health AD Genetics Sib Pair collection
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT00064870
Related Trials
Novel Augmentation of DAOIB and Antioxidant for Early Dementia
NCT064675391 location
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
NCT06937229241 locations
Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease
NCT071782101 location
Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease
NCT041233141 location
Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease
NCT0483830110 locations